Combinatorial strategies for the induction of immunogenic cell death
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10294962" target="_blank" >RIV/00216208:11130/15:10294962 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/15:10294962
Result on the web
<a href="http://dx.doi.org/10.3389/fimmu.2015.00187" target="_blank" >http://dx.doi.org/10.3389/fimmu.2015.00187</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fimmu.2015.00187" target="_blank" >10.3389/fimmu.2015.00187</a>
Alternative languages
Result language
angličtina
Original language name
Combinatorial strategies for the induction of immunogenic cell death
Original language description
The term "immunogenic cell death" (ICD) is commonly employed to indicate a peculiar instance of regulated cell death (RCD) that engages the adaptive arm of the immune system. The inoculation of cancer cells undergoing ICD into immunocompetent animals elicits a specific immune response associated with the establishment of immunological memory. Only a few agents are intrinsically endowed with the ability to trigger ICD. These include a few chemotherapeutics that are routinely employed in the clinic, likedoxorubicin, mitoxantrone, oxaliplatin, and cyclophosphamide, as well as some agents that have not yet been approved for use in humans. Accumulating clinical data indicate that the activation of adaptive immune responses against dying cancer cells is associated with improved disease outcome in patients affected by various neoplasms. Thus, novel therapeutic regimens that trigger ICD are urgently awaited. Here, we discuss current combinatorial approaches to convert otherwise non-immunogeni
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Immunology
ISSN
1664-3224
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
24. duben
Country of publishing house
CH - SWITZERLAND
Number of pages
11
Pages from-to
—
UT code for WoS article
000354936800001
EID of the result in the Scopus database
—